Published in Int J Obes (Lond) on July 24, 2007
Marijuana-based drugs: innovative therapeutics or designer drugs of abuse? Mol Interv (2011) 1.38
Role of educational level in the relationship between Body Mass Index (BMI) and health-related quality of life (HRQL) among rural Spanish women. BMC Public Health (2009) 0.96
Factors associated with health-related quality of life among overweight or obese adults. J Clin Nurs (2013) 0.92
Metabolic syndrome and health-related quality of life in Iranian population. J Res Med Sci (2011) 0.90
Empirically derived dietary patterns and health-related quality of life in the SUN project. PLoS One (2013) 0.87
Dietary fat intake and quality of life: the SUN project. Nutr J (2011) 0.87
Correlates of perceived health related quality of life in obese, overweight and normal weight older adults: an observational study. BMC Public Health (2014) 0.84
Coping strategies, health-related quality of life and psychiatric history in patients with aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien) (2010) 0.84
Motivations to eat healthily in older Dutch adults--a cross sectional study. Int J Behav Nutr Phys Act (2014) 0.80
Assessing the impact of dietary habits on health-related quality of life requires contextual measurement tools. Front Pharmacol (2015) 0.79
Psychological disturbances and quality of life in obese and infertile women and men. Int J Endocrinol (2012) 0.77
Factors Affecting Gender Differences in the Association between Health-Related Quality of Life and Metabolic Syndrome Components: Tehran Lipid and Glucose Study. PLoS One (2015) 0.77
Health-related Quality of Life Among People Participating in a Metabolic Syndrome E-screening Program: A Web-based Study. Int J Prev Med (2016) 0.76
Is persistence of metabolic syndrome associated with poor health-related quality of life in non-diabetic Iranian adults? Tehran Lipid and Glucose Study. J Diabetes Investig (2014) 0.75
Multidisciplinary intervention in obese adolescents: predictors of dropout. Einstein (Sao Paulo) (2015) 0.75
Lifestyle Intervention on Metabolic Syndrome and its Impact on Quality of Life: A Randomized Controlled Trial. Arq Bras Cardiol (2016) 0.75
Correlates of quality of life of pre-obese and obese patients: a pharmacy-based cross-sectional survey. BMC Public Health (2009) 0.75
Metabolic syndrome and quality of life: a systematic review. Rev Lat Am Enfermagem (2016) 0.75
Does a modified STarT Back Tool predict outcome with a broader group of musculoskeletal patients than back pain? A secondary analysis of cohort data. BMJ Open (2016) 0.75
Cross-validation of item selection and scoring for the SF-12 Health Survey in nine countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 10.03
Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes (2001) 9.67
Association of nonalcoholic fatty liver disease with insulin resistance. Am J Med (1999) 5.65
Translating health status questionnaires and evaluating their quality: the IQOLA Project approach. International Quality of Life Assessment. J Clin Epidemiol (1998) 5.15
Prevalence of undertreatment in cancer pain. A review of published literature. Ann Oncol (2008) 4.70
Metformin in non-alcoholic steatohepatitis. Lancet (2001) 3.63
The equivalence of SF-36 summary health scores estimated using standard and country-specific algorithms in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.40
The factor structure of the SF-36 Health Survey in 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 3.37
Stopping a trial early in oncology: for patients or for industry? Ann Oncol (2008) 3.06
Factors associated with poor health-related quality of life of patients with cirrhosis. Gastroenterology (2001) 2.74
International Quality of Life Assessment (IQOLA) Project. Qual Life Res (1992) 2.64
Clinical features and natural history of nonalcoholic steatosis syndromes. Semin Liver Dis (2001) 2.56
ASA Physical Status and age predict morbidity after three surgical procedures. Ann Surg (1994) 2.52
Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon? Diabetologia (2008) 2.32
Vegetable versus animal protein diet in cirrhotic patients with chronic encephalopathy. A randomized cross-over comparison. J Intern Med (1993) 2.24
Tests of data quality, scaling assumptions, and reliability of the SF-36 in eleven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.22
Quality, evolution, and clinical implications of randomized, controlled trials on the treatment of lung cancer. A lost opportunity for meta-analysis. JAMA (1989) 2.18
Cross-cultural comparisons of the content of SF-36 translations across 10 countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 2.05
Testing the equivalence of translations of widely used response choice labels: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.86
Use of structural equation modeling to test the construct validity of the SF-36 Health Survey in ten countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.79
Dipeptidyl peptidase-4 inhibitors and pancreatitis risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.76
Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.71
Comparison of Rasch and summated rating scales constructed from SF-36 physical functioning items in seven countries: results from the IQOLA Project. International Quality of Life Assessment. J Clin Epidemiol (1998) 1.69
Psychopathological and clinical features of outpatients with an eating disorder not otherwise specified. Eat Weight Disord (2001) 1.65
Hepatic steatosis in obese patients: clinical aspects and prognostic significance. Obes Rev (2004) 1.62
Psychological status and depression in patients with liver cirrhosis. Dig Liver Dis (2005) 1.62
The impact of patient management guidelines on the care of breast, colorectal, and ovarian cancer patients in Italy. Med Care (1991) 1.62
Does a drug do better when it is new? Ann Oncol (2002) 1.61
Efficacy of a surveillance program for early detection of hepatocellular carcinoma. Cancer (1996) 1.57
Health-related quality of life in dialysis patients. A report from an Italian study using the SF-36 Health Survey. DIA-QOL Group. Nephrol Dial Transplant (1999) 1.57
Pediatric risk of mortality: an assessment of its performance in a sample of 26 Italian intensive care units. Crit Care Med (1998) 1.50
Dipeptidyl peptidase-4 inhibitors and cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2012) 1.49
Relationship between plasma leptin levels and the tumor necrosis factor-alpha system in obese subjects. Int J Obes Relat Metab Disord (1999) 1.49
Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab (2009) 1.49
Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease. A decalogue from the Italian Association for the Study of the Liver (AISF) Expert Committee. Dig Liver Dis (2010) 1.45
Comprehensive drug screening in decision making of patients attending the emergency department for suspected drug overdose. Emerg Med J (2003) 1.44
Inhibitors of 5α-reductase-related side effects in patients seeking medical care for sexual dysfunction. J Endocrinol Invest (2012) 1.42
Effect of metformin on cardiovascular events and mortality: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2011) 1.42
Insulin resistance in nonalcoholic fatty liver disease. Curr Pharm Des (2010) 1.41
The impact of cancer treatment guidelines on actual practice in Italian general hospitals: the case of ovarian cancer. Ann Oncol (1990) 1.40
Lipid, lipoprotein, and apolipoprotein assessment during an 8-wk very-low-calorie diet. Am J Clin Nutr (1992) 1.37
Effect of obesity and body fat distribution on sex hormones and insulin in men. Metabolism (1991) 1.36
Effects of new smoking regulations in Italy. Ann Oncol (2005) 1.32
Glycaemic efficacy of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors as add-on therapy to metformin in subjects with type 2 diabetes-a review and meta analysis. Diabetes Obes Metab (2012) 1.30
Impact of different customization strategies in the performance of a general severity score. Crit Care Med (1997) 1.30
Type 2 diabetes mellitus and testosterone: a meta-analysis study. Int J Androl (2010) 1.30
Efficacy and safety of sodium glucose co-transport-2 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.29
Complexity of attrition in the treatment of obesity: clues from a structured telephone interview. Int J Obes (Lond) (2006) 1.29
Clinical and hormonal characteristics of obese amenorrheic hyperandrogenic women before and after weight loss. J Clin Endocrinol Metab (1989) 1.29
One model, several results: the paradox of the Hosmer-Lemeshow goodness-of-fit test for the logistic regression model. J Epidemiol Biostat (2000) 1.26
WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetes. Diabet Med (2004) 1.24
The association of pancreatitis with antidiabetic drug use: gaining insight through the FDA pharmacovigilance database. Acta Diabetol (2011) 1.23
Association of hypogonadism and type II diabetes in men attending an outpatient erectile dysfunction clinic. Int J Impot Res (2006) 1.20
Dipeptydil peptidase-4 inhibitors in type 2 diabetes: a meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis (2009) 1.18
Subjective health status assessment: evaluation of the Italian version of the SF-12 Health Survey. Results from the MiOS Project. J Epidemiol Biostat (2001) 1.15
Frailty and muscle metabolism dysregulation in the elderly. Biogerontology (2010) 1.14
Fluoxetine and fluvoxamine combined with individual cognitive-behaviour therapy in binge eating disorder: a one-year follow-up study. Psychother Psychosom (2001) 1.10
Screening for binge eating disorder in obese outpatients. Compr Psychiatry (2000) 1.10
Evaluation of the uniformity of fit of general outcome prediction models. Intensive Care Med (1998) 1.10
Non-alcoholic fatty liver and insulin resistance: a cause-effect relationship? Dig Liver Dis (2004) 1.09
Gender-dependent alterations in serum leptin in alcoholic cirrhosis. Gastroenterology (1998) 1.07
Hypogonadism and metabolic syndrome. J Endocrinol Invest (2011) 1.07
Rosiglitazone stimulates adipogenesis and decreases osteoblastogenesis in human mesenchymal stem cells. J Endocrinol Invest (2007) 1.07
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: an open question. Nutr Metab Cardiovasc Dis (2007) 1.07
Blood alcohol concentration and management of road trauma patients in the emergency department. J Trauma (2001) 1.07
The role of attitudes, beliefs, and personal characteristics of Italian physicians in the surgical treatment of early breast cancer. Am J Public Health (1991) 1.07
Interrelationships between body weight, body fat distribution and insulin in obese women before and after hypocaloric feeding and weight loss. Ann Nutr Metab (1989) 1.06
Prognostic indicators in compensated cirrhosis. Am J Gastroenterol (1991) 1.06
Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. Int J Androl (2009) 1.04
The course of galactose elimination capacity in patients with alcoholic cirrhosis: possible use as a surrogate marker for death. Hepatology (1996) 1.04
The study of APOA1, APOC3 and APOA4 variability in healthy ageing people reveals another paradox in the oldest old subjects. Ann Hum Genet (2003) 1.04
Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score. Dig Dis Sci (1991) 1.04
Health-related quality of life in patients with thyroid disorders. Qual Life Res (2004) 1.03
Appropriateness of hospital use: an overview of Italian studies. Int J Qual Health Care (1995) 1.03
Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndrome. J Endocrinol Invest (2008) 1.03
Prospective validation of a proposal for diagnosis and management of patients attending the emergency department for mild head injury. J Neurol Neurosurg Psychiatry (2004) 1.02
Functional hepatic flow and Doppler-assessed total hepatic flow in control subjects and in patients with cirrhosis. J Hepatol (1995) 1.02
Effects of glucagon-like peptide-1 receptor agonists on cardiovascular risk: a meta-analysis of randomized clinical trials. Diabetes Obes Metab (2013) 1.01
Prognostic significance of diabetes in patients with cirrhosis. Hepatology (1994) 1.01
Leptin increases serotonin turnover by inhibition of brain nitric oxide synthesis. J Clin Invest (1999) 1.01
A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters. J Endocrinol Invest (2009) 1.01
The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. Int J Androl (2009) 1.01
Echo-Doppler measurement of splanchnic blood flow in control and cirrhotic subjects. J Clin Ultrasound (1986) 1.01
Endometrial resection versus vaginal hysterectomy for menorrhagia: long-term clinical and quality-of-life outcomes. Am J Obstet Gynecol (1997) 1.00
Aging and pathogenesis of erectile dysfunction. Int J Impot Res (2004) 1.00
WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose tolerance. Int J Obes Relat Metab Disord (2002) 1.00
Diabetes mellitus as a risk factor for depression. A meta-analysis of longitudinal studies. Diabetes Res Clin Pract (2012) 0.99
Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 2 diabetes: a meta-analysis. Exp Clin Endocrinol Diabetes (2009) 0.99
Psychological outcomes in women with early breast cancer. BMJ (1990) 0.99
Insulin-dependent metabolism of branched-chain amino acids in obesity. Metabolism (1984) 0.98
Anticatabolic effect of branched-chain amino acid-enriched solutions in patients with liver cirrhosis. Hepatology (1982) 0.97
Splanchnic haemodynamics in non-alcoholic fatty liver disease: effect of a dietary/pharmacological treatment. A pilot study. Dig Liver Dis (2004) 0.97